My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 543

1.

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.

Zoli W, Ulivi P, Tesei A, Fabbri F, Rosetti M, Maltoni R, Giunchi DC, Ricotti L, Brigliadori G, Vannini I, Amadori D.

Breast Cancer Res. 2005;7(5):R681-9. Epub 2005 Jun 22.PMID: 16168113 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines.

Zoli W, Ricotti L, Barzanti F, Dal Susino M, Frassineti GL, Milandri C, Casadei Giunchi D, Amadori D.

Int J Cancer. 1999 Jan 29;80(3):413-6.PMID: 9935183 [PubMed - indexed for MEDLINE]Related articles

3.

Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.

Shi P, Wang MM, Jiang LY, Liu HT, Sun JZ.

Chin Med J (Engl). 2008 Oct 20;121(20):1975-9.PMID: 19080259 [PubMed - indexed for MEDLINE]Related articlesFree article

4.

Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.

Brenes O, Arce F, Gätjens-Boniche O, Díaz C.

Biomed Pharmacother. 2007 Jul;61(6):347-55. Epub 2007 Mar 9.PMID: 17399942 [PubMed - indexed for MEDLINE]Related articles

5.

The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG.

Cancer Res. 2002 May 1;62(9):2644-9.PMID: 11980662 [PubMed - indexed for MEDLINE]Related articlesFree article

6.

Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53.

Borralho PM, Moreira da Silva IB, Aranha MM, Albuquerque C, Nobre Leitão C, Steer CJ, Rodrigues CM.

Biochim Biophys Acta. 2007 Jan;1772(1):40-7. Epub 2006 Sep 16.PMID: 17056233 [PubMed - indexed for MEDLINE]Related articles

7.

In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.

Ricotti L, Tesei A, De Paola F, Ulivi P, Frassineti GL, Milandri C, Amadori D, Zoli W.

Clin Cancer Res. 2003 Feb;9(2):900-5.PMID: 12576465 [PubMed - indexed for MEDLINE]Related articlesFree article

8.

In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.

Tanaka R, Ariyama H, Qin B, Takii Y, Baba E, Mitsugi K, Harada M, Nakano S.

Cancer Chemother Pharmacol. 2005 Jun;55(6):595-601. Epub 2005 Feb 25.PMID: 15731917 [PubMed - indexed for MEDLINE]Related articles

9.

The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.

Longley DB, Allen WL, McDermott U, Wilson TR, Latif T, Boyer J, Lynch M, Johnston PG.

Clin Cancer Res. 2004 May 15;10(10):3562-71.PMID: 15161716 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.

Qin B, Tanaka R, Shibata Y, Arita S, Ariyama H, Kusaba H, Baba E, Harada M, Nakano S.

Anticancer Drugs. 2006 Apr;17(4):445-53.PMID: 16550003 [PubMed - indexed for MEDLINE]Related articles

11.

Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.

Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, Yamamura T, Hashimoto-Tamaoki T.

Cancer Res. 2001 Feb 1;61(3):1029-37.PMID: 11221829 [PubMed - indexed for MEDLINE]Related articlesFree article

12.

A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.

Park SJ, Wu CH, Safa AR.

Anticancer Res. 2004 Jan-Feb;24(1):123-31.PMID: 15015586 [PubMed - indexed for MEDLINE]Related articles

13.

Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.

Das JR, Fryar-Tita EB, Zhou Y, Green S, Southerland WM, Bowen D.

Anticancer Res. 2007 Nov-Dec;27(6B):3791-9.PMID: 18225534 [PubMed - indexed for MEDLINE]Related articles

14.

in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer.

Inoue Y, Tanaka K, Hiro J, Yoshiyama S, Toiyama Y, Eguchi T, Miki C, Kusunoki M.

Int J Oncol. 2006 Feb;28(2):479-86.PMID: 16391804 [PubMed - indexed for MEDLINE]Related articles

15.

Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.

Chung WH, Sung BH, Kim SS, Rhim H, Kuh HJ.

Int J Oncol. 2009 Jun;34(6):1669-79.PMID: 19424586 [PubMed - indexed for MEDLINE]Related articles

16.

Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines.

Lee TK, Lau TC, Ng IO.

Cancer Chemother Pharmacol. 2002 Jan;49(1):78-86.PMID: 11855756 [PubMed - indexed for MEDLINE]Related articles

17.

Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells.

Chadderton A, Villeneuve DJ, Gluck S, Kirwan-Rhude AF, Gannon BR, Blais DE, Parissenti AM.

Breast Cancer Res Treat. 2000 Feb;59(3):231-44.PMID: 10832593 [PubMed - indexed for MEDLINE]Related articles

18.

Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.

Coudray AM, Louvet C, Kornprobst M, Raymond E, André T, Tournigand C, Faivre S, De Gramont A, Larsen AK, Gespach C.

Int J Oncol. 2005 Aug;27(2):553-61.PMID: 16010439 [PubMed - indexed for MEDLINE]Related articles

19.

Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.

Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.

Cell Biochem Biophys. 2009;55(2):95-105. Epub 2009 Jul 11.PMID: 19593673 [PubMed - indexed for MEDLINE]Related articles

20.

Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.

Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL.

Br J Cancer. 2000 Nov;83(10):1380-6.PMID: 11044365 [PubMed - indexed for MEDLINE]Related articlesFree article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed
Write to the Help Desk